A novel prognostic index for diffuse large B-cell lymphoma combined baseline metabolic tumour volume with clinical and pathological risk factors

T. Yuan,X. Chen,Y. Zhang,M. Wei,H. Zhu,Z. Yang,X. Wang

Nuclear medicine communications（2023）

引用 0|浏览4

暂无评分

摘要

The novel index including tumour burden and clinicopathological features may help predict outcome of DLBCL (clinicaltrials.gov identifier: NCT02928861).

查看译文

关键词

baseline metabolic tumour volume,lymphoma,novel prognostic index,b-cell

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要